Ashley Hall

Insider Reports History

Entity
Individual
Location
C/O Esperion Therapeutics Inc., 3891 Ranchero Drive Suite 150, Ann Arbor, MI
Signature
/s/ Jennifer P. Lam, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ashley Hall:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Reneo Pharmaceuticals, Inc. Chief Development Officer Common Stock 39.6K $249K $6.28 Aug 28, 2023 Direct
Reneo Pharmaceuticals, Inc. Chief Development Officer Stock option (right to buy) 109K Aug 28, 2023 Direct

Insider Reports Filed by Ashley Hall

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RPHM Reneo Pharmaceuticals, Inc. Aug 28, 2023 3 -$69.9K 4 Aug 29, 2023 Chief Development Officer
RPHM Reneo Pharmaceuticals, Inc. Dec 9, 2022 1 $0 4 Dec 13, 2022 Chief Development Officer
RPHM Reneo Pharmaceuticals, Inc. Nov 12, 2021 2 $0 4 Nov 15, 2021 Chief Development Officer
RPHM Reneo Pharmaceuticals, Inc. Oct 11, 2020 0 $0 3 Oct 14, 2021 Chief Development Officer